CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease
Open Access
- 4 August 2023
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 31 (1-2) , 31-44
Abstract
Parkinson`s disease (PD) is the second most prevalent neurodegenerative disease, and different gene therapy strategies have been used as experimental treatments. As a proof-of-concept for the treatment of PD, we used SAM, a CRISPR gene activation system, to activate the endogenous tyrosine hydroxylase gene (th) of astrocytes to produce dopamine (DA) in the striatum of 6-OHDA-lesioned rats. Potential sgRNAs within the rat th promoter region were tested, and the expression of the Th protein was determined in the C6 glial cell line. Employing pseudo-lentivirus, the SAM complex and the selected sgRNA were transferred into cultures of rat astrocytes, and gene expression and Th protein synthesis were ascertained; furthermore, DA release into the culture medium was determined by HPLC. The DA-producing astrocytes were implanted into the striatum of 6-OHDA hemiparkinsonian rats. We observed motor behavior improvement in the lesioned rats that received DA-astrocytes compared to lesioned rats receiving astrocytes that did not produce DA. Our data indicate that the SAM-induced expression of the astrocyte´s endogenous th gene can generate DA-producing astrocytes that effectively reduce the motor asymmetry induced by the lesion.Keywords
All Related Versions
This publication has 76 references indexed in Scilit:
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cellsNature Biotechnology, 2013
- Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based reviewJournal of Neurology, 2013
- The History of Parkinson's Disease: Early Clinical Descriptions and Neurological TherapiesCold Spring Harbor Perspectives in Medicine, 2011
- Amphetamine induced rotation in the assessment of lesions and grafts in the unilateral rat model of Parkinson's diseaseEuropean Neuropsychopharmacology, 2007
- Developing a preclinical model of Parkinson's disease: A study of behaviour in rats with graded 6-OHDA lesionsBehavioural Brain Research, 2006
- Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat ModelScience, 2002
- Real-Time Dynamics of Dopamine Released from Neuronal Transplants in Experimental Parkinson's DiseaseExperimental Neurology, 2000
- Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental ParkinsonismGene Therapy, 1998
- Behavioural Effect of Engineered Cells that Synthesize L‐DOPA or Dopamine after Grafting into the Rat NeostriatumEuropean Journal of Neuroscience, 1990